_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
503468982,7/16/2014 15:32:19,,1324299133,7/16/2014 15:31:50,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 15:36:40,,1324300618,7/16/2014 15:36:21,instagc,0.9028,13763729,USA,"","",75.182.89.225,no_relation,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 15:54:24,,1324308098,7/16/2014 15:53:49,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 16:15:27,,1324320175,7/16/2014 16:14:40,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,PARKINSON'S DISEASE causes LEVODOPA,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 16:24:14,,1324323640,7/16/2014 16:23:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 17:02:24,,1324338927,7/16/2014 17:02:08,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 18:18:53,,1324397399,7/16/2014 18:18:18,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,PARKINSON'S DISEASE causes LEVODOPA,66,54,,84,62,causes,0.348155311911396,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468983,7/16/2014 15:53:43,,1324307809,7/16/2014 15:53:18,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,HYPERTENSION treats CANDESARTAN CILEXETIL,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 16:51:28,,1324335116,7/16/2014 16:50:49,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,HYPERTENSION treats CANDESARTAN CILEXETIL,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 17:29:58,,1324349316,7/16/2014 17:29:46,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 20:36:26,,1324464812,7/16/2014 20:35:43,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 21:38:39,,1324493414,7/16/2014 21:38:14,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 22:02:34,,1324502692,7/16/2014 22:02:03,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 22:19:17,,1324508718,7/16/2014 22:18:46,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468984,7/16/2014 15:39:09,,1324301689,7/16/2014 15:38:49,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,STATUS EPILEPTICUS diagnosed by DIAZEPAM,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 16:21:37,,1324322634,7/16/2014 16:21:08,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 20:03:02,,1324449660,7/16/2014 20:02:40,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 21:39:18,,1324493666,7/16/2014 21:39:01,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 22:02:02,,1324502488,7/16/2014 22:01:24,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,STATUS EPILEPTICUS diagnosed by DIAZEPAM,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 23:11:30,,1324529240,7/16/2014 23:10:51,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 23:33:13,,1324538966,7/16/2014 23:32:41,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468985,7/16/2014 15:29:08,,1324297987,7/16/2014 15:28:08,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 15:29:29,,1324298116,7/16/2014 15:29:19,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:01:05,,1324311278,7/16/2014 16:00:49,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:41:22,,1324331433,7/16/2014 16:41:12,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:48:35,,1324334200,7/16/2014 16:47:53,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 20:43:57,,1324467733,7/16/2014 20:43:46,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,TOLERANCE causes DRUG,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 21:38:12,,1324493263,7/16/2014 21:37:47,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468986,7/16/2014 15:38:14,,1324301181,7/16/2014 15:37:54,instagc,0.9028,13763729,USA,"","",75.182.89.225,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 16:52:20,,1324335407,7/16/2014 16:51:47,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 17:06:45,,1324340208,7/16/2014 17:06:29,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 20:42:17,,1324467161,7/16/2014 20:41:59,prodege,0.6448,26325260,GBR,"","",79.64.25.64,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 20:44:17,,1324467852,7/16/2014 20:44:13,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,STATUS EPILEPTICUS treats DIAZEPAM,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 22:55:47,,1324523740,7/16/2014 22:54:54,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 23:10:50,,1324528988,7/16/2014 23:10:27,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.936329177569044,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468987,7/16/2014 15:26:15,,1324297153,7/16/2014 15:25:57,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 15:43:10,,1324303261,7/16/2014 15:42:56,instagc,0.8194,18960682,GBR,"","",86.29.147.112,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 16:50:48,,1324334904,7/16/2014 16:50:08,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 17:25:39,,1324346438,7/16/2014 17:24:40,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,PETECHIAE is location of SKIN,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 22:18:45,,1324508464,7/16/2014 22:17:35,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,no_relation,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 23:10:46,,1324528949,7/16/2014 23:10:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/17/2014 02:18:33,,1324670518,7/17/2014 02:17:42,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PETECHIAE is location of SKIN,337,372,,340,381,is location of,0.596284793999944,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468988,7/16/2014 15:23:48,,1324296405,7/16/2014 15:23:33,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 15:49:40,,1324306051,7/16/2014 15:49:18,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 15:52:33,,1324307339,7/16/2014 15:52:04,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,PYRIDOXINE DEPENDENT SEIZURES treats PYRIDOXINE,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 17:06:45,,1324340212,7/16/2014 17:06:29,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 19:30:43,,1324434769,7/16/2014 19:29:40,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 22:53:14,,1324522599,7/16/2014 22:52:21,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 22:56:58,,1324524241,7/16/2014 22:56:28,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.990147542976674,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468989,7/16/2014 15:23:33,,1324296343,7/16/2014 15:23:15,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 15:29:29,,1324298130,7/16/2014 15:29:19,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 15:31:51,,1324298987,7/16/2014 15:31:37,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 16:47:17,,1324333700,7/16/2014 16:47:11,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 17:02:30,,1324338940,7/16/2014 17:02:25,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,COMPLICATION OF PREGNANCY causes PREECLAMPSIA,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 19:24:48,,1324431863,7/16/2014 19:24:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 19:31:23,,1324435148,7/16/2014 19:30:45,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.89553347118899,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468990,7/16/2014 15:23:14,,1324296236,7/16/2014 15:22:54,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) causes HEMOPHAGOCYTOSIS,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 15:25:37,,1324296971,7/16/2014 15:25:24,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,HEMOPHAGOCYTOSIS causes VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 15:26:11,,1324297117,7/16/2014 15:25:57,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) causes HEMOPHAGOCYTOSIS,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 16:20:25,,1324322144,7/16/2014 16:19:49,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) causes HEMOPHAGOCYTOSIS,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 16:47:25,,1324333726,7/16/2014 16:47:18,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) causes HEMOPHAGOCYTOSIS,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 20:42:55,,1324467370,7/16/2014 20:42:19,prodege,0.6448,26325260,GBR,"","",79.64.25.64,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) causes HEMOPHAGOCYTOSIS,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468990,7/16/2014 23:33:33,,1324539070,7/16/2014 23:33:14,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,124,2,,139,49,causes,0.861640436855329,901971-FS1-4,"A VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS) is a non neoplastic, generalized histiocytic proliferation with prominent HEMOPHAGOCYTOSIS associated with a systemic viral infection.",HEMOPHAGOCYTOSIS,VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME (VAHS),RO-disease_has_finding
503468991,7/16/2014 15:22:52,,1324296145,7/16/2014 15:22:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,no_relation,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 15:49:16,,1324305873,7/16/2014 15:49:05,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,ULCERATIVE COLITIS causes INFLAMMATORY BOWEL DISEASES,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 18:03:58,,1324381893,7/16/2014 18:03:28,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,ULCERATIVE COLITIS causes INFLAMMATORY BOWEL DISEASES,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 19:45:20,,1324441934,7/16/2014 19:44:36,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 20:10:18,,1324452895,7/16/2014 20:10:12,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,ULCERATIVE COLITIS causes INFLAMMATORY BOWEL DISEASES,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 20:42:55,,1324467357,7/16/2014 20:42:19,prodege,0.6448,26325260,GBR,"","",79.64.25.64,INFLAMMATORY BOWEL DISEASES causes ULCERATIVE COLITIS,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468991,7/16/2014 22:54:53,,1324523384,7/16/2014 22:54:38,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,44,79,,70,97,causes,0.615457454896664,902198-FS1-4,"29  Inflammatory bowel disease   Typically, INFLAMMATORY BOWEL DISEASES (e.g., ULCERATIVE COLITIS and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",INFLAMMATORY BOWEL DISEASES,ULCERATIVE COLITIS,RO-disease_has_primary_anatomic_site
503468992,7/16/2014 16:20:25,,1324322146,7/16/2014 16:19:49,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,PERIODIC ALTERNATING HYPERTENSION causes ADRENAL PHEOCHROMOCYTOMA,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 16:25:08,,1324323958,7/16/2014 16:24:43,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,ADRENAL PHEOCHROMOCYTOMA causes PERIODIC ALTERNATING HYPERTENSION,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 17:07:28,,1324340518,7/16/2014 17:07:02,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 17:42:42,,1324359690,7/16/2014 17:42:11,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,ADRENAL PHEOCHROMOCYTOMA causes PERIODIC ALTERNATING HYPERTENSION,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 19:24:18,,1324431638,7/16/2014 19:23:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,ADRENAL PHEOCHROMOCYTOMA causes PERIODIC ALTERNATING HYPERTENSION,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 20:40:05,,1324466281,7/16/2014 20:39:21,prodege,0.6448,26325260,GBR,"","",79.64.25.64,ADRENAL PHEOCHROMOCYTOMA causes PERIODIC ALTERNATING HYPERTENSION,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468992,7/16/2014 23:10:46,,1324528948,7/16/2014 23:10:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,ADRENAL PHEOCHROMOCYTOMA causes PERIODIC ALTERNATING HYPERTENSION,81,29,,113,53,causes,0.843274042711568,902699-FS1-4,We present a patient with an ADRENAL PHEOCHROMOCYTOMA with an unusual pattern of PERIODIC ALTERNATING HYPERTENSION and hypotension.,PERIODIC ALTERNATING HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503468993,7/16/2014 15:32:06,,1324299056,7/16/2014 15:31:52,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 17:02:02,,1324338834,7/16/2014 17:01:51,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,CRANIOCEREBRAL TRAUMA causes POSTTRAUMATIC EPILEPSY,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 17:04:00,,1324339421,7/16/2014 17:03:42,clixsense,0.5597,19638651,USA,"","",173.23.121.63,CRANIOCEREBRAL TRAUMA causes POSTTRAUMATIC EPILEPSY,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 19:27:03,,1324432999,7/16/2014 19:26:25,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,CRANIOCEREBRAL TRAUMA causes POSTTRAUMATIC EPILEPSY,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 19:27:59,,1324433487,7/16/2014 19:27:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,CRANIOCEREBRAL TRAUMA causes POSTTRAUMATIC EPILEPSY,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 20:44:11,,1324467831,7/16/2014 20:44:06,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,no_relation,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468993,7/16/2014 23:49:19,,1324545424,7/16/2014 23:48:56,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,CRANIOCEREBRAL TRAUMA causes POSTTRAUMATIC EPILEPSY,46,89,,67,110,causes,0.800640769025436,900492-FS1-4,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503468994,7/16/2014 15:38:34,,1324301371,7/16/2014 15:38:14,instagc,0.9028,13763729,USA,"","",75.182.89.225,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 16:22:46,,1324323016,7/16/2014 16:22:32,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:24:03,,1324345735,7/16/2014 17:23:25,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:30:38,,1324349786,7/16/2014 17:30:22,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:44:50,,1324361816,7/16/2014 17:44:36,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 19:24:18,,1324431640,7/16/2014 19:23:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,RHEUMATOID ARTHRITIS is location of JOINTS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 20:10:25,,1324452948,7/16/2014 20:10:19,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468995,7/16/2014 15:22:28,,1324295990,7/16/2014 15:22:07,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,no_relation,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 15:25:53,,1324297058,7/16/2014 15:25:40,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,AGGRESSIVE CLINICAL COURSE treats PLASMA CELL LEUKAEMIA,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 15:43:59,,1324303685,7/16/2014 15:43:51,instagc,0.8194,18960682,GBR,"","",86.29.147.112,AGGRESSIVE CLINICAL COURSE treats PLASMA CELL LEUKAEMIA,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 16:01:21,,1324311447,7/16/2014 16:01:06,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,PLASMA CELL LEUKAEMIA treats AGGRESSIVE CLINICAL COURSE,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 16:40:31,,1324330956,7/16/2014 16:40:02,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,AGGRESSIVE CLINICAL COURSE treats PLASMA CELL LEUKAEMIA,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 16:47:39,,1324333828,7/16/2014 16:47:34,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,no_relation,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468995,7/16/2014 16:50:55,,1324334924,7/16/2014 16:50:23,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,63,17,,88,38,treats,0.457495710997814,902607-FS1-2,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503468996,7/16/2014 15:49:55,,1324306199,7/16/2014 15:49:46,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 16:20:15,,1324322087,7/16/2014 16:19:49,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 16:22:22,,1324322885,7/16/2014 16:21:45,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 18:16:50,,1324395480,7/16/2014 18:16:08,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:10:18,,1324452901,7/16/2014 20:10:12,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:36:15,,1324464713,7/16/2014 20:35:40,bitcoinget,0.8333,27766138,USA,AL,Birmingham,12.208.238.130,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:44:30,,1324467954,7/16/2014 20:44:25,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,CALCIFICATIONS diagnosed by DCIS,38,61,,51,65,diagnosed by,0.702246883176783,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468997,7/16/2014 16:16:34,,1324320704,7/16/2014 16:16:07,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 16:38:20,,1324329624,7/16/2014 16:38:04,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 17:29:08,,1324348688,7/16/2014 17:28:53,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 18:15:34,,1324393876,7/16/2014 18:14:41,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 19:09:25,,1324424228,7/16/2014 19:08:44,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 20:02:39,,1324449495,7/16/2014 20:02:12,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468997,7/16/2014 23:49:34,,1324545517,7/16/2014 23:49:21,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,STOMACH is location of GASTRIC CARCINOMA,37,64,,43,81,is location of,0.984731927834662,902110-FS1-9,"Applications of endoscopic US in the STOMACH include staging of GASTRIC CARCINOMA localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",STOMACH,GASTRIC CARCINOMA,RO-disease_has_primary_anatomic_site
503468998,7/16/2014 16:00:48,,1324311078,7/16/2014 16:00:23,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,WARFARIN causes PREGNANCY,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 19:54:07,,1324446174,7/16/2014 19:53:46,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 20:01:42,,1324449191,7/16/2014 20:01:18,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 23:10:01,,1324528710,7/16/2014 23:09:33,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 23:11:14,,1324529130,7/16/2014 23:10:47,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 23:28:40,,1324537141,7/16/2014 23:28:23,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468998,7/16/2014 23:33:59,,1324539258,7/16/2014 23:33:35,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,140,156,,147,165,causes,0.855186110494136,901253-FS1-4,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503468999,7/16/2014 15:22:28,,1324295987,7/16/2014 15:22:07,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,GRAVES' DISEASE causes THYROTOXICOSIS,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/16/2014 15:26:32,,1324297227,7/16/2014 15:26:19,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,GRAVES' DISEASE causes THYROTOXICOSIS,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/16/2014 15:39:09,,1324301688,7/16/2014 15:38:49,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,GRAVES' DISEASE causes THYROTOXICOSIS,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/16/2014 16:01:05,,1324311276,7/16/2014 16:00:49,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,THYROTOXICOSIS causes GRAVES' DISEASE,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/16/2014 19:30:43,,1324434768,7/16/2014 19:29:40,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,THYROTOXICOSIS causes GRAVES' DISEASE,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/16/2014 22:49:46,,1324521155,7/16/2014 22:49:11,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503468999,7/17/2014 02:18:33,,1324670523,7/17/2014 02:17:42,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,THYROTOXICOSIS causes GRAVES' DISEASE,76,101,,90,115,causes,0.657595949221429,900139-FS1-4,We previously reported that allergic rhinitis was an aggravating factor for GRAVES' DISEASE and that THYROTOXICOSIS relapsed 2 months after an allergic attack.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503469000,7/16/2014 15:43:51,,1324303625,7/16/2014 15:43:36,instagc,0.8194,18960682,GBR,"","",86.29.147.112,no_relation,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 16:00:21,,1324310873,7/16/2014 16:00:01,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,SUDDEN INFANT DEATHS treats SIDS,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 19:28:56,,1324433995,7/16/2014 19:27:41,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 19:46:33,,1324442520,7/16/2014 19:46:10,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 21:38:58,,1324493529,7/16/2014 21:38:41,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 22:02:02,,1324502484,7/16/2014 22:01:24,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,SIDS treats SUDDEN INFANT DEATHS,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469000,7/16/2014 22:49:10,,1324520943,7/16/2014 22:48:16,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,SIDS treats SUDDEN INFANT DEATHS,41,164,,44,184,treats,0.437594974493684,900196-FS1-2,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469001,7/16/2014 15:31:36,,1324298900,7/16/2014 15:31:08,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 15:40:25,,1324302140,7/16/2014 15:39:47,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,POSTTRAUMATIC EPILEPSY diagnosed by CRANIOCEREBRAL TRAUMA,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 15:49:19,,1324305899,7/16/2014 15:49:10,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:09:00,,1324341036,7/16/2014 17:08:42,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:19:50,,1324344347,7/16/2014 17:19:32,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:30:21,,1324349566,7/16/2014 17:29:59,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 19:29:39,,1324434325,7/16/2014 19:28:58,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,POSTTRAUMATIC EPILEPSY diagnosed by CRANIOCEREBRAL TRAUMA,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469002,7/16/2014 15:34:24,,1324299764,7/16/2014 15:34:19,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 15:41:31,,1324302650,7/16/2014 15:40:59,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 15:50:45,,1324306554,7/16/2014 15:49:44,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 16:24:07,,1324323584,7/16/2014 16:23:41,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 16:50:55,,1324334925,7/16/2014 16:50:23,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 18:25:41,,1324400259,7/16/2014 18:25:10,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469002,7/16/2014 20:03:02,,1324449659,7/16/2014 20:02:40,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,ALL TRANS RETINOIC ACID (ATRA) treats ACUTE PROMYELOCYTIC LEUKEMIA (APL),74,0,,107,30,treats,1,908323-FS1-2,ALL TRANS RETINOIC ACID (ATRA) is the drug of choice for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL),ACUTE PROMYELOCYTIC LEUKEMIA (APL),ALL TRANS RETINOIC ACID (ATRA),RO-may_treat
503469003,7/16/2014 15:29:18,,1324298029,7/16/2014 15:29:05,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,IVIG treats IDIOPATHIC THROMBOCYTOPENIC PURPURA,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 15:50:19,,1324306353,7/16/2014 15:49:59,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 16:01:21,,1324311449,7/16/2014 16:01:06,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,IDIOPATHIC THROMBOCYTOPENIC PURPURA treats IVIG,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 16:23:46,,1324323417,7/16/2014 16:23:25,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,IVIG treats IDIOPATHIC THROMBOCYTOPENIC PURPURA,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 16:24:45,,1324323842,7/16/2014 16:24:08,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 17:07:14,,1324340439,7/16/2014 17:06:46,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,IVIG treats IDIOPATHIC THROMBOCYTOPENIC PURPURA,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469003,7/16/2014 18:04:33,,1324382537,7/16/2014 18:04:11,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,IVIG treats IDIOPATHIC THROMBOCYTOPENIC PURPURA,34,16,,68,20,treats,0.884651736929383,908158-FS1-2,"Indications for IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,RO-may_treat
503469004,7/16/2014 16:18:46,,1324321555,7/16/2014 16:18:17,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,AL AMYLOIDOSIS causes MARKED HEPATOMEGALY,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/16/2014 19:27:40,,1324433319,7/16/2014 19:27:05,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,AL AMYLOIDOSIS causes MARKED HEPATOMEGALY,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/16/2014 22:51:34,,1324521894,7/16/2014 22:50:42,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,AL AMYLOIDOSIS causes MARKED HEPATOMEGALY,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/16/2014 23:33:59,,1324539261,7/16/2014 23:33:35,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/16/2014 23:50:04,,1324545627,7/16/2014 23:49:35,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,AL AMYLOIDOSIS causes MARKED HEPATOMEGALY,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/17/2014 02:21:32,,1324673500,7/17/2014 02:20:30,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,no_relation,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469004,7/17/2014 02:29:23,,1324681460,7/17/2014 02:28:43,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,AL AMYLOIDOSIS causes MARKED HEPATOMEGALY,61,99,,79,113,causes,0.923760430703401,902820-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469005,7/16/2014 15:27:35,,1324297472,7/16/2014 15:27:13,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,MMMT causes SARCOMATOUS COMPONENT,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 15:29:55,,1324298291,7/16/2014 15:29:32,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 15:30:24,,1324298465,7/16/2014 15:29:45,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,SARCOMATOUS COMPONENT causes MMMT,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 15:49:58,,1324306150,7/16/2014 15:49:41,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 16:40:00,,1324330647,7/16/2014 16:39:41,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,MMMT causes SARCOMATOUS COMPONENT,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 17:19:16,,1324344186,7/16/2014 17:18:53,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469005,7/16/2014 17:45:51,,1324362975,7/16/2014 17:45:24,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,no_relation,79,42,,99,46,causes,0.5,901872-FS1-4,This case fulfills all the criteria of an MMMT in having a carcinomatous and a SARCOMATOUS COMPONENT but differs from cases of MMMT in women in that the sarcomatous component had decidualized.,SARCOMATOUS COMPONENT,MMMT,RO-disease_has_finding
503469006,7/16/2014 15:23:48,,1324296401,7/16/2014 15:23:33,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 15:49:40,,1324306052,7/16/2014 15:49:18,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 17:45:51,,1324362974,7/16/2014 17:45:24,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 18:17:32,,1324396264,7/16/2014 18:16:51,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 19:08:44,,1324423792,7/16/2014 19:07:49,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,COELIAC DISEASE diagnosed by GLUTEN,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 20:34:56,,1324464173,7/16/2014 20:34:13,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 20:41:15,,1324466780,7/16/2014 20:40:22,prodege,0.6448,26325260,GBR,"","",79.64.25.64,COELIAC DISEASE diagnosed by GLUTEN,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469007,7/16/2014 15:25:37,,1324296984,7/16/2014 15:25:24,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 15:36:59,,1324300737,7/16/2014 15:36:41,instagc,0.9028,13763729,USA,"","",75.182.89.225,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA causes VENTRICULAR TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 15:43:51,,1324303633,7/16/2014 15:43:36,instagc,0.8194,18960682,GBR,"","",86.29.147.112,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 16:23:24,,1324323310,7/16/2014 16:22:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 17:06:04,,1324339931,7/16/2014 17:05:26,clixsense,0.5597,19638651,USA,"","",173.23.121.63,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA causes VENTRICULAR TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 17:41:06,,1324358129,7/16/2014 17:40:27,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 20:41:57,,1324467071,7/16/2014 20:41:16,prodege,0.6448,26325260,GBR,"","",79.64.25.64,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.816496580927726,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469008,7/16/2014 15:33:52,,1324299585,7/16/2014 15:33:37,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,MEDICATIONS treats TOLERANCE,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 16:22:50,,1324323066,7/16/2014 16:22:23,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 16:50:20,,1324334758,7/16/2014 16:49:25,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 17:01:44,,1324338739,7/16/2014 17:01:36,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,no_relation,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 17:25:39,,1324346406,7/16/2014 17:24:40,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,MEDICATIONS treats TOLERANCE,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 18:36:13,,1324405169,7/16/2014 18:36:08,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469008,7/16/2014 19:11:20,,1324425149,7/16/2014 19:10:40,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,no_relation,185,220,,195,229,treats,0.875189948987367,903789-FS1-2,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti CD11/CD18 antibodies and anti complement, and b) MEDICATIONS that enhance metabolic TOLERANCE such as glucose insulin potassium solution and inhibitors of the Na+/H+ ion exchange system.",MEDICATIONS,TOLERANCE,RO-has_causative_agent
503469009,7/16/2014 15:28:49,,1324297892,7/16/2014 15:28:07,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,HEMORRHAGIC FEVER WITH RENAL SYNDROME treats HANTAAN VIRUS,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 15:43:59,,1324303686,7/16/2014 15:43:51,instagc,0.8194,18960682,GBR,"","",86.29.147.112,HANTAAN VIRUS treats HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 16:23:46,,1324323416,7/16/2014 16:23:25,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,HEMORRHAGIC FEVER WITH RENAL SYNDROME treats HANTAAN VIRUS,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 17:07:02,,1324340356,7/16/2014 17:06:05,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 19:54:28,,1324446338,7/16/2014 19:54:08,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 23:09:32,,1324528531,7/16/2014 23:08:48,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469009,7/16/2014 23:12:54,,1324529820,7/16/2014 23:12:29,cotter,0.5,14794434,USA,OH,Bryan,98.28.82.243,HANTAAN VIRUS treats HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,treats,0.753778361444409,903692-FS1-2,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469010,7/16/2014 15:24:14,,1324296570,7/16/2014 15:23:49,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 15:30:45,,1324298608,7/16/2014 15:30:19,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 16:21:07,,1324322426,7/16/2014 16:20:27,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 17:08:38,,1324340914,7/16/2014 17:08:18,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 19:29:39,,1324434327,7/16/2014 19:28:58,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 19:46:33,,1324442533,7/16/2014 19:46:10,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 23:30:29,,1324537742,7/16/2014 23:30:00,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.970142500145332,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469011,7/16/2014 15:48:55,,1324305755,7/16/2014 15:48:37,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 16:16:57,,1324320834,7/16/2014 16:16:36,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 16:37:05,,1324328794,7/16/2014 16:36:52,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 17:01:50,,1324338774,7/16/2014 17:01:45,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 17:07:35,,1324340576,7/16/2014 17:07:16,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 18:04:51,,1324382820,7/16/2014 18:04:34,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469011,7/16/2014 21:39:42,,1324493890,7/16/2014 21:39:20,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.89553347118899,906549-FS1-2,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
503469012,7/16/2014 15:26:32,,1324297228,7/16/2014 15:26:19,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 15:55:46,,1324308654,7/16/2014 15:55:10,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 16:18:46,,1324321557,7/16/2014 16:18:17,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 16:47:09,,1324333642,7/16/2014 16:47:02,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 17:08:06,,1324340712,7/16/2014 17:07:36,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 17:44:35,,1324361533,7/16/2014 17:44:11,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 20:10:25,,1324452947,7/16/2014 20:10:19,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469013,7/16/2014 15:23:14,,1324296233,7/16/2014 15:22:54,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 15:50:45,,1324306604,7/16/2014 15:49:44,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 20:09:54,,1324452656,7/16/2014 20:09:47,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 22:01:23,,1324502237,7/16/2014 22:00:56,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 22:17:34,,1324508034,7/16/2014 22:17:09,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 23:10:14,,1324528777,7/16/2014 23:09:31,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469013,7/16/2014 23:48:54,,1324545270,7/16/2014 23:48:33,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,ABSENCE EPILEPSY causes SEIZURES,120,18,,127,34,causes,0.886796350347864,904936-FS1-4,"The final form of ABSENCE EPILEPSY is epilepsy with myoclonic absences, a rare disorder with a specific form of absence SEIZURES",SEIZURES,ABSENCE EPILEPSY,RO-has_definitional_manifestation
503469014,7/16/2014 15:36:40,,1324300617,7/16/2014 15:36:21,instagc,0.9028,13763729,USA,"","",75.182.89.225,no_relation,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 15:49:09,,1324305832,7/16/2014 15:48:56,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,ATOPIC DERMATITIS causes ASTHMA,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 15:49:58,,1324306168,7/16/2014 15:49:41,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 16:41:22,,1324331459,7/16/2014 16:41:12,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,ATOPIC DERMATITIS causes ASTHMA,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 16:51:51,,1324335263,7/16/2014 16:51:32,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,ASTHMA causes ATOPIC DERMATITIS,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 17:24:38,,1324345967,7/16/2014 17:24:04,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,no_relation,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469014,7/16/2014 23:09:00,,1324528309,7/16/2014 23:08:33,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,57,87,,62,104,causes,0.38490017945975,906019-FS1-4,"The atopic diseases of childhood consist of the triad of ASTHMA allergic rhinitis, and ATOPIC DERMATITIS",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
503469015,7/16/2014 16:36:51,,1324328622,7/16/2014 16:36:28,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 16:47:01,,1324333583,7/16/2014 16:46:46,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 17:04:33,,1324339554,7/16/2014 17:04:00,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 17:07:14,,1324340438,7/16/2014 17:06:46,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 18:03:10,,1324381092,7/16/2014 18:02:21,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,ASCITES causes HEPATOMA,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 19:27:40,,1324433322,7/16/2014 19:27:05,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 22:20:12,,1324509280,7/16/2014 22:19:41,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469016,7/16/2014 15:29:18,,1324298030,7/16/2014 15:29:05,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 15:30:18,,1324298435,7/16/2014 15:29:56,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 15:34:11,,1324299707,7/16/2014 15:33:53,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 15:37:54,,1324301072,7/16/2014 15:37:24,instagc,0.9028,13763729,USA,"","",75.182.89.225,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 15:40:57,,1324302410,7/16/2014 15:40:27,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 16:20:15,,1324322086,7/16/2014 16:19:49,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469016,7/16/2014 16:39:39,,1324330470,7/16/2014 16:39:31,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,TRICHURIS TRICHIURA causes TRICHURIASIS,61,30,,79,42,causes,0.985329278164293,903707-FS1-4,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIS TRICHIURA,TRICHURIASIS,RO-has_causative_agent
503469017,7/16/2014 15:29:54,,1324298287,7/16/2014 15:29:47,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,VARICELLA causes CHICKENPOX,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/16/2014 15:31:51,,1324298986,7/16/2014 15:31:37,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/16/2014 15:52:03,,1324307097,7/16/2014 15:51:31,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/16/2014 17:19:50,,1324344346,7/16/2014 17:19:32,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/16/2014 17:31:01,,1324350024,7/16/2014 17:30:39,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/16/2014 23:28:40,,1324537128,7/16/2014 23:28:23,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469017,7/17/2014 02:31:11,,1324683253,7/17/2014 02:30:35,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,83,107,,91,117,causes,0.566138517072298,903771-FS1-4,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease VARICELLA also known as CHICKENPOX and the adult disease herpes zoster, also known as shingles.",VARICELLA,CHICKENPOX,RO-has_causative_agent
503469018,7/16/2014 15:44:12,,1324303756,7/16/2014 15:44:00,instagc,0.8194,18960682,GBR,"","",86.29.147.112,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 16:48:35,,1324334199,7/16/2014 16:47:53,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 18:16:06,,1324394648,7/16/2014 18:15:35,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 22:02:34,,1324502693,7/16/2014 22:02:03,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 23:49:34,,1324545516,7/16/2014 23:49:21,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/17/2014 00:27:15,,1324563531,7/17/2014 00:26:28,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/17/2014 02:20:32,,1324672641,7/17/2014 02:20:24,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469019,7/16/2014 15:29:46,,1324298246,7/16/2014 15:29:38,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 15:29:55,,1324298289,7/16/2014 15:29:32,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 15:55:46,,1324308655,7/16/2014 15:55:10,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 16:20:46,,1324322262,7/16/2014 16:20:16,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 18:18:53,,1324397400,7/16/2014 18:18:18,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 18:36:07,,1324405122,7/16/2014 18:35:59,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 20:02:39,,1324449496,7/16/2014 20:02:12,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.74535599249993,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469020,7/16/2014 15:49:55,,1324306130,7/16/2014 15:49:46,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/16/2014 17:19:31,,1324344244,7/16/2014 17:19:17,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/16/2014 17:24:03,,1324345736,7/16/2014 17:23:25,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/16/2014 21:37:45,,1324493111,7/16/2014 21:37:15,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/16/2014 22:20:12,,1324509279,7/16/2014 22:19:41,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/16/2014 22:56:27,,1324524017,7/16/2014 22:56:11,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469020,7/17/2014 00:59:28,,1324593543,7/17/2014 00:59:12,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.943456353049726,907922-FS1-2,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
503469021,7/16/2014 15:29:37,,1324298203,7/16/2014 15:29:30,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 15:51:30,,1324306866,7/16/2014 15:50:45,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 19:40:28,,1324439428,7/16/2014 19:39:54,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 19:54:07,,1324446176,7/16/2014 19:53:46,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 20:00:52,,1324448871,7/16/2014 19:59:55,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 23:09:29,,1324528494,7/16/2014 23:09:01,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/17/2014 00:27:47,,1324564038,7/17/2014 00:27:16,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469022,7/16/2014 15:30:18,,1324298434,7/16/2014 15:29:56,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,CALCIFICATIONS causes DCIS,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 17:22:07,,1324344998,7/16/2014 17:21:24,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,no_relation,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 17:31:01,,1324350020,7/16/2014 17:30:39,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,DCIS causes CALCIFICATIONS,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 17:43:50,,1324360815,7/16/2014 17:43:18,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 18:35:28,,1324404851,7/16/2014 18:35:04,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 22:17:34,,1324508033,7/16/2014 22:17:09,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,CALCIFICATIONS causes DCIS,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469022,7/16/2014 23:11:46,,1324529352,7/16/2014 23:11:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,CALCIFICATIONS causes DCIS,38,61,,51,65,causes,0.702246883176783,902978-FS1-4,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469023,7/16/2014 16:22:46,,1324323017,7/16/2014 16:22:32,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 16:23:40,,1324323380,7/16/2014 16:23:09,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 16:47:33,,1324333768,7/16/2014 16:47:26,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,no_relation,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 19:09:25,,1324424230,7/16/2014 19:08:44,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 19:45:42,,1324442111,7/16/2014 19:45:21,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 21:38:58,,1324493528,7/16/2014 21:38:41,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 22:49:46,,1324521157,7/16/2014 22:49:11,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469024,7/16/2014 15:43:35,,1324303472,7/16/2014 15:43:22,instagc,0.8194,18960682,GBR,"","",86.29.147.112,no_relation,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 17:29:58,,1324349314,7/16/2014 17:29:46,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 23:08:47,,1324528253,7/16/2014 23:08:01,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 23:29:06,,1324537247,7/16/2014 23:28:41,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 02:20:23,,1324672398,7/17/2014 02:20:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 02:31:55,,1324683928,7/17/2014 02:31:12,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 03:07:59,,1324720630,7/17/2014 03:07:39,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.729324957489473,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469025,7/16/2014 15:25:21,,1324296924,7/16/2014 15:25:08,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:27:35,,1324297471,7/16/2014 15:27:13,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,HEADACHES causes MIGRAINE,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:38:14,,1324301182,7/16/2014 15:37:54,instagc,0.9028,13763729,USA,"","",75.182.89.225,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:53:26,,1324307659,7/16/2014 15:52:59,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:54:24,,1324308096,7/16/2014 15:53:49,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 16:38:03,,1324329389,7/16/2014 16:37:49,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 16:40:31,,1324330971,7/16/2014 16:40:02,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,MIGRAINE causes HEADACHES,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469026,7/16/2014 15:37:23,,1324300867,7/16/2014 15:37:00,instagc,0.9028,13763729,USA,"","",75.182.89.225,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 15:49:03,,1324305806,7/16/2014 15:48:47,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,WARFARIN contraindicates PREGNANCY,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 15:49:33,,1324306025,7/16/2014 15:49:20,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 16:37:20,,1324328917,7/16/2014 16:37:07,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 17:06:04,,1324339930,7/16/2014 17:05:26,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 19:39:53,,1324439060,7/16/2014 19:39:15,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,no_relation,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 20:03:28,,1324449824,7/16/2014 20:03:03,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,140,156,,147,165,contraindicates,0.366508333068916,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469027,7/16/2014 15:27:10,,1324297382,7/16/2014 15:26:35,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 15:43:20,,1324303326,7/16/2014 15:43:11,instagc,0.8194,18960682,GBR,"","",86.29.147.112,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 16:00:21,,1324310875,7/16/2014 16:00:01,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,DEPRESSION treats TRICYCLIC ANTIDEPRESSANTS,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 16:16:57,,1324320827,7/16/2014 16:16:36,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,DEPRESSION treats TRICYCLIC ANTIDEPRESSANTS,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 18:35:58,,1324405070,7/16/2014 18:35:49,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 20:40:21,,1324466366,7/16/2014 20:40:06,prodege,0.6448,26325260,GBR,"","",79.64.25.64,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469027,7/16/2014 22:04:01,,1324503297,7/16/2014 22:03:07,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,185,197,,194,222,treats,0.981980506061966,907737-FS1-2,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), DEPRESSION (TRICYCLIC ANTIDEPRESSANTS venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
503469028,7/16/2014 19:27:17,,1324433105,7/16/2014 19:26:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,HEMORRHAGIC FEVER WITH RENAL SYNDROME causes HANTAAN VIRUS,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 20:40:05,,1324466274,7/16/2014 20:39:21,prodege,0.6448,26325260,GBR,"","",79.64.25.64,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 22:54:37,,1324523276,7/16/2014 22:54:07,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:10:26,,1324528827,7/16/2014 23:10:02,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:31:08,,1324538064,7/16/2014 23:30:31,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:34:23,,1324539431,7/16/2014 23:34:01,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/17/2014 00:59:59,,1324594144,7/17/2014 00:59:29,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469029,7/16/2014 16:17:59,,1324321244,7/16/2014 16:16:58,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 16:37:49,,1324329258,7/16/2014 16:37:21,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 17:09:25,,1324341182,7/16/2014 17:09:01,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 17:29:44,,1324349124,7/16/2014 17:29:09,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 17:44:11,,1324361139,7/16/2014 17:44:02,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 19:40:28,,1324439431,7/16/2014 19:39:54,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,no_relation,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469029,7/16/2014 20:44:24,,1324467928,7/16/2014 20:44:18,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,BONE MARROW is location of MYELOGENOUS LEUKEMIA,100,126,,110,146,is location of,0.848528137423857,902331-FS1-9,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in BONE MARROW (BM) cells of MYELOGENOUS LEUKEMIA patients in a manner similar to that reported using normal BM cells.,BONE MARROW,MYELOGENOUS LEUKEMIA,RO-disease_has_primary_anatomic_site
503469030,7/16/2014 15:49:44,,1324306078,7/16/2014 15:49:34,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 15:50:19,,1324306362,7/16/2014 15:49:59,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 15:59:36,,1324310533,7/16/2014 15:59:21,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 16:23:40,,1324323382,7/16/2014 16:23:09,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 16:38:20,,1324329625,7/16/2014 16:38:04,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 17:07:43,,1324340610,7/16/2014 17:07:23,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,BONE PAIN causes LAMELAR BONE,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 18:17:32,,1324396298,7/16/2014 18:16:51,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469031,7/16/2014 15:22:52,,1324296139,7/16/2014 15:22:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,SCABIES causes MITES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 15:26:33,,1324297235,7/16/2014 15:26:12,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 15:33:37,,1324299496,7/16/2014 15:33:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 16:20:46,,1324322254,7/16/2014 16:20:16,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 16:51:28,,1324335119,7/16/2014 16:50:49,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 19:28:56,,1324433996,7/16/2014 19:27:41,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 19:39:53,,1324439046,7/16/2014 19:39:15,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,MITES causes SCABIES,116,94,,120,101,causes,0.964763821237732,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469032,7/16/2014 16:51:44,,1324335217,7/16/2014 16:50:57,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 17:43:17,,1324360277,7/16/2014 17:42:43,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 19:24:48,,1324431864,7/16/2014 19:24:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 20:01:42,,1324449189,7/16/2014 20:01:18,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 22:04:01,,1324503296,7/16/2014 22:03:07,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 22:54:53,,1324523383,7/16/2014 22:54:38,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 23:09:00,,1324528312,7/16/2014 23:08:33,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469033,7/16/2014 15:52:03,,1324307100,7/16/2014 15:51:31,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,CHRONIC DIARRHEA causes LOOSE STOOLS,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 16:22:10,,1324322832,7/16/2014 16:21:53,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,CHRONIC DIARRHEA causes LOOSE STOOLS,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 16:51:51,,1324335264,7/16/2014 16:51:32,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,LOOSE STOOLS causes CHRONIC DIARRHEA,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 18:35:58,,1324405071,7/16/2014 18:35:49,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,CHRONIC DIARRHEA causes LOOSE STOOLS,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 20:44:05,,1324467782,7/16/2014 20:43:58,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,CHRONIC DIARRHEA causes LOOSE STOOLS,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 22:04:46,,1324503520,7/16/2014 22:04:02,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,CHRONIC DIARRHEA causes LOOSE STOOLS,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469033,7/16/2014 23:10:01,,1324528704,7/16/2014 23:09:33,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,62,0,,73,16,causes,0.935414346693485,904910-FS1-4,CHRONIC DIARRHEA can be defined as the passage of more than 3 LOOSE STOOLS per day during more than 4 weeks.,LOOSE STOOLS,CHRONIC DIARRHEA,RO-has_definitional_manifestation
503469034,7/16/2014 15:30:41,,1324298575,7/16/2014 15:30:25,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 15:38:48,,1324301470,7/16/2014 15:38:24,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 16:21:52,,1324322713,7/16/2014 16:20:47,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:09:25,,1324341201,7/16/2014 17:09:01,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:18:52,,1324344046,7/16/2014 17:18:38,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:30:38,,1324349809,7/16/2014 17:30:22,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:43:50,,1324360820,7/16/2014 17:43:18,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469035,7/16/2014 15:26:11,,1324297116,7/16/2014 15:25:57,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,VIRUS causes VIRAL INFECTION,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 15:48:45,,1324305702,7/16/2014 15:48:22,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 18:36:13,,1324405158,7/16/2014 18:36:08,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 19:11:20,,1324425147,7/16/2014 19:10:40,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,VIRUS causes VIRAL INFECTION,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 19:31:23,,1324435147,7/16/2014 19:30:45,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,VIRUS causes VIRAL INFECTION,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 22:04:46,,1324503521,7/16/2014 22:04:02,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,VIRUS causes VIRAL INFECTION,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469035,7/16/2014 23:33:13,,1324538965,7/16/2014 23:32:41,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,VIRUS causes VIRAL INFECTION,50,89,,54,104,causes,0.848874687627165,903880-FS1-4,We apply well established principles of modelling VIRUS dynamics to the study of chronic VIRAL INFECTION demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.,VIRUS,VIRAL INFECTION,RO-has_causative_agent
503469036,7/16/2014 16:47:39,,1324333829,7/16/2014 16:47:34,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 16:49:23,,1324334477,7/16/2014 16:48:36,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 18:18:17,,1324397068,7/16/2014 18:17:33,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 20:09:45,,1324452602,7/16/2014 20:09:38,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 22:50:41,,1324521496,7/16/2014 22:49:47,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,CATARACT FORMATION is location of LENS,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/17/2014 00:28:11,,1324564409,7/17/2014 00:27:47,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/17/2014 02:21:32,,1324673499,7/17/2014 02:20:30,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469037,7/16/2014 23:10:26,,1324528826,7/16/2014 23:10:02,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/16/2014 23:29:28,,1324537409,7/16/2014 23:29:08,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/16/2014 23:33:33,,1324539069,7/16/2014 23:33:14,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 00:28:35,,1324564768,7/17/2014 00:28:12,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 02:18:49,,1324670853,7/17/2014 02:18:34,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 02:23:09,,1324675115,7/17/2014 02:22:14,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 03:07:37,,1324720203,7/17/2014 03:06:58,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.966736489045664,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469038,7/16/2014 15:31:20,,1324298775,7/16/2014 15:30:46,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,MARKED HEPATOMEGALY diagnosed by AL AMYLOIDOSIS,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 15:34:18,,1324299727,7/16/2014 15:34:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,MARKED HEPATOMEGALY diagnosed by AL AMYLOIDOSIS,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 16:23:24,,1324323311,7/16/2014 16:22:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,AL AMYLOIDOSIS diagnosed by MARKED HEPATOMEGALY,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 16:52:59,,1324335680,7/16/2014 16:52:28,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,MARKED HEPATOMEGALY diagnosed by AL AMYLOIDOSIS,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 17:01:50,,1324338773,7/16/2014 17:01:45,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,MARKED HEPATOMEGALY diagnosed by AL AMYLOIDOSIS,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 17:19:31,,1324344243,7/16/2014 17:19:17,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,AL AMYLOIDOSIS diagnosed by MARKED HEPATOMEGALY,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469038,7/16/2014 20:10:04,,1324452754,7/16/2014 20:09:55,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,MARKED HEPATOMEGALY diagnosed by AL AMYLOIDOSIS,61,99,,79,113,diagnosed by,0.346410161513775,902820-FS1-13,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing MARKED HEPATOMEGALY in a patient with AL AMYLOIDOSIS of the liver and spleen.,MARKED HEPATOMEGALY,AL AMYLOIDOSIS,RO-disease_may_have_finding
503469039,7/16/2014 17:02:24,,1324338928,7/16/2014 17:02:08,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,PATHOLOGIC FRACTURES causes SOLITARY BONE METASTASIS,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 21:38:39,,1324493413,7/16/2014 21:38:14,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 22:56:27,,1324524016,7/16/2014 22:56:11,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 23:11:14,,1324529145,7/16/2014 23:10:47,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 23:30:29,,1324537767,7/16/2014 23:30:00,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/17/2014 00:50:28,,1324584510,7/17/2014 00:49:28,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/17/2014 02:22:13,,1324674192,7/17/2014 02:21:33,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,SOLITARY BONE METASTASIS causes PATHOLOGIC FRACTURES,149,81,,168,105,causes,0.554700196225229,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469040,7/16/2014 15:37:54,,1324301070,7/16/2014 15:37:24,instagc,0.9028,13763729,USA,"","",75.182.89.225,no_relation,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/16/2014 15:39:43,,1324301896,7/16/2014 15:39:12,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,BLISTERING SKIN DISEASE PEMPHIGUS causes SKIN WOUNDS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/16/2014 15:44:12,,1324303761,7/16/2014 15:44:00,instagc,0.8194,18960682,GBR,"","",86.29.147.112,BLISTERING SKIN DISEASE PEMPHIGUS causes SKIN WOUNDS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/16/2014 16:00:48,,1324311082,7/16/2014 16:00:23,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,SKIN WOUNDS causes BLISTERING SKIN DISEASE PEMPHIGUS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/16/2014 17:42:10,,1324359201,7/16/2014 17:41:47,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,SKIN WOUNDS causes BLISTERING SKIN DISEASE PEMPHIGUS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/17/2014 00:59:11,,1324593237,7/17/2014 00:58:38,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,BLISTERING SKIN DISEASE PEMPHIGUS causes SKIN WOUNDS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469040,7/17/2014 02:31:11,,1324683256,7/17/2014 02:30:35,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,BLISTERING SKIN DISEASE PEMPHIGUS causes SKIN WOUNDS,88,133,,98,166,causes,0.790569415042095,902059-FS1-4,The activation of the urokinase system has been observed during re epithelialization of SKIN WOUNDS and in lesions of the autoimmune BLISTERING SKIN DISEASE PEMPHIGUS,SKIN WOUNDS,BLISTERING SKIN DISEASE PEMPHIGUS,RO-disease_has_primary_anatomic_site
503469041,7/16/2014 16:19:23,,1324321736,7/16/2014 16:19:03,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,PLASMA GLUCOSE treats HYPOGLYCEMIA,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 18:26:24,,1324400588,7/16/2014 18:25:42,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 18:35:48,,1324404955,7/16/2014 18:35:38,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 20:03:28,,1324449822,7/16/2014 20:03:03,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 22:49:10,,1324520945,7/16/2014 22:48:16,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 22:56:10,,1324523925,7/16/2014 22:55:49,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469041,7/16/2014 23:08:47,,1324528251,7/16/2014 23:08:01,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,173,109,,184,123,treats,0.480384461415261,908276-FS1-2,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469042,7/16/2014 15:32:06,,1324299055,7/16/2014 15:31:52,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 15:49:33,,1324306024,7/16/2014 15:49:20,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,GALLBLADDER diagnosed by ACUTE CHOLECYSTITIS,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 17:09:00,,1324341037,7/16/2014 17:08:42,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,ACUTE CHOLECYSTITIS diagnosed by GALLBLADDER,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 17:22:07,,1324344991,7/16/2014 17:21:24,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,GALLBLADDER diagnosed by ACUTE CHOLECYSTITIS,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 20:36:26,,1324464811,7/16/2014 20:35:43,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,ACUTE CHOLECYSTITIS diagnosed by GALLBLADDER,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 20:44:11,,1324467833,7/16/2014 20:44:06,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,GALLBLADDER diagnosed by ACUTE CHOLECYSTITIS,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469042,7/16/2014 22:18:45,,1324508463,7/16/2014 22:17:35,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,ACUTE CHOLECYSTITIS diagnosed by GALLBLADDER,31,133,,41,152,diagnosed by,0.970494958830946,905242-FS1-13,"Percutaneous aspiration of the GALLBLADDER was performed for nine hospitalized patients, most commonly to establish the diagnosis of ACUTE CHOLECYSTITIS and its complications in the critically ill patient or patient with sepsis.",GALLBLADDER,ACUTE CHOLECYSTITIS,RO-has_finding_site
503469043,7/16/2014 15:24:14,,1324296565,7/16/2014 15:23:49,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,ARTERIAL OCCLUSION is location of BILATERAL INTERNAL CAROTID ARTERIES,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 15:25:21,,1324296923,7/16/2014 15:25:08,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,ARTERIAL OCCLUSION is location of BILATERAL INTERNAL CAROTID ARTERIES,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 15:49:09,,1324305833,7/16/2014 15:48:56,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,BILATERAL INTERNAL CAROTID ARTERIES is location of ARTERIAL OCCLUSION,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 16:21:52,,1324322715,7/16/2014 16:20:47,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,BILATERAL INTERNAL CAROTID ARTERIES is location of ARTERIAL OCCLUSION,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 16:41:11,,1324331361,7/16/2014 16:40:32,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,ARTERIAL OCCLUSION is location of BILATERAL INTERNAL CAROTID ARTERIES,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 17:08:38,,1324340919,7/16/2014 17:08:18,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,BILATERAL INTERNAL CAROTID ARTERIES is location of ARTERIAL OCCLUSION,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469043,7/16/2014 19:27:17,,1324433102,7/16/2014 19:26:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,86,175,,120,193,is location of,0.842700971600384,905037-FS1-9,The disease is characterized by stenosis or occlusion of the terminal portions of the BILATERAL INTERNAL CAROTID ARTERIES and abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION,BILATERAL INTERNAL CAROTID ARTERIES,ARTERIAL OCCLUSION,RO-has_finding_site
503469044,7/16/2014 15:28:39,,1324297848,7/16/2014 15:28:17,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,FAMILIAL HYPERCHOLESTEROLEMIA causes EZETIMIBE,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/16/2014 16:52:23,,1324335432,7/16/2014 16:51:56,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,FAMILIAL HYPERCHOLESTEROLEMIA causes EZETIMIBE,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/16/2014 17:08:28,,1324340847,7/16/2014 17:08:08,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,EZETIMIBE causes FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/16/2014 19:45:42,,1324442113,7/16/2014 19:45:21,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/16/2014 23:29:58,,1324537559,7/16/2014 23:29:29,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/16/2014 23:49:19,,1324545428,7/16/2014 23:48:56,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,FAMILIAL HYPERCHOLESTEROLEMIA causes EZETIMIBE,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469044,7/17/2014 00:27:15,,1324563566,7/17/2014 00:26:28,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,125,112,,153,121,causes,0.707106781186547,907942-FS1-4,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469045,7/16/2014 17:45:22,,1324362381,7/16/2014 17:45:06,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,PHEOCHROMOCYTOMA causes HYPERTENSION,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/16/2014 18:16:06,,1324394651,7/16/2014 18:15:35,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,PHEOCHROMOCYTOMA causes HYPERTENSION,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/16/2014 18:35:28,,1324404850,7/16/2014 18:35:04,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,HYPERTENSION causes PHEOCHROMOCYTOMA,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/16/2014 22:52:20,,1324522208,7/16/2014 22:51:36,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PHEOCHROMOCYTOMA causes HYPERTENSION,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/16/2014 23:09:29,,1324528503,7/16/2014 23:09:01,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,PHEOCHROMOCYTOMA causes HYPERTENSION,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/16/2014 23:48:54,,1324545268,7/16/2014 23:48:33,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,PHEOCHROMOCYTOMA causes HYPERTENSION,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469045,7/17/2014 02:19:04,,1324671170,7/17/2014 02:18:49,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,HYPERTENSION causes PHEOCHROMOCYTOMA,49,70,,60,86,causes,0.948683298050514,902958-FS1-4,Evidence: ? Patients with identifiable causes of HYPERTENSION such as PHEOCHROMOCYTOMA and renal disease have unique perioperative considerations ( 12.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503469046,7/16/2014 16:03:57,,1324312948,7/16/2014 16:03:18,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/16/2014 16:38:03,,1324329387,7/16/2014 16:37:49,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/16/2014 17:24:38,,1324345969,7/16/2014 17:24:04,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/16/2014 19:59:54,,1324448559,7/16/2014 19:59:17,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/16/2014 20:44:17,,1324467851,7/16/2014 20:44:13,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,HYPERTENSION treats ACEBUTOLOL,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/17/2014 00:59:28,,1324593548,7/17/2014 00:59:12,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469046,7/17/2014 02:23:32,,1324675498,7/17/2014 02:23:10,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,1,907499-FS1-2,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
503469047,7/16/2014 15:51:30,,1324306865,7/16/2014 15:50:45,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/16/2014 23:29:28,,1324537398,7/16/2014 23:29:08,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/16/2014 23:34:23,,1324539433,7/16/2014 23:34:01,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/17/2014 02:23:52,,1324675784,7/17/2014 02:23:32,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,EPILEPTIC SEIZURES causes PSYCHOGENIC NON EPILEPTIC SEIZURES,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/17/2014 02:33:15,,1324685415,7/17/2014 02:32:40,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/17/2014 03:08:18,,1324720952,7/17/2014 03:08:00,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,EPILEPTIC SEIZURES causes PSYCHOGENIC NON EPILEPTIC SEIZURES,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469047,7/17/2014 03:39:44,,1324751227,7/17/2014 03:38:57,instagc,0.5238,20183814,USA,"","",166.182.81.199,no_relation,141,157,,174,175,causes,0.365148371670111,904653-FS1-4,"Depending on video EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had PSYCHOGENIC NON EPILEPTIC SEIZURES four of whom had psychogenic non epileptic seizures plus true EPILEPTIC SEIZURES",PSYCHOGENIC NON EPILEPTIC SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503469048,7/16/2014 15:28:49,,1324297893,7/16/2014 15:28:07,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 17:07:22,,1324340504,7/16/2014 17:06:11,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,HYPERPIGMENTATION treats HYDROQUINONE,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 17:18:16,,1324343900,7/16/2014 17:18:02,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 18:04:10,,1324382129,7/16/2014 18:03:59,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 18:35:48,,1324404954,7/16/2014 18:35:38,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 23:10:50,,1324528982,7/16/2014 23:10:27,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 23:11:46,,1324529353,7/16/2014 23:11:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469049,7/16/2014 17:01:44,,1324338738,7/16/2014 17:01:36,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,no_relation,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 17:29:08,,1324348690,7/16/2014 17:28:53,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 19:59:54,,1324448563,7/16/2014 19:59:17,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 22:19:41,,1324508954,7/16/2014 22:19:17,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 22:50:41,,1324521497,7/16/2014 22:49:47,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 22:56:10,,1324523923,7/16/2014 22:55:49,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469049,7/16/2014 23:12:54,,1324529819,7/16/2014 23:12:29,cotter,0.5,14794434,USA,OH,Bryan,98.28.82.243,ANTIPYRINE treats EAR PAIN (OTALGIA EARACHE,93,54,,117,64,treats,1,907711-FS1-2,"r  Otic Pain  Used alone or in fixed combination with ANTIPYRINE for the temporary relief of EAR PAIN (OTALGIA EARACHE associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",EAR PAIN (OTALGIA EARACHE,ANTIPYRINE,RO-may_treat
503469050,7/16/2014 15:31:50,,1324298979,7/16/2014 15:31:21,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 16:16:34,,1324320682,7/16/2014 16:16:07,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,X LINKED HYDROCEPHALUS causes MASA SYNDROME,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 16:37:49,,1324329259,7/16/2014 16:37:21,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 17:02:07,,1324338852,7/16/2014 17:02:03,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,MASA SYNDROME causes X LINKED HYDROCEPHALUS,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 17:04:33,,1324339555,7/16/2014 17:04:00,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 19:27:59,,1324433486,7/16/2014 19:27:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 22:01:23,,1324502238,7/16/2014 22:00:56,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,MASA SYNDROME causes X LINKED HYDROCEPHALUS,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469051,7/16/2014 15:28:16,,1324297711,7/16/2014 15:27:36,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 15:41:31,,1324302661,7/16/2014 15:40:59,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 16:04:38,,1324313400,7/16/2014 16:04:03,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 16:24:45,,1324323852,7/16/2014 16:24:08,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 17:02:07,,1324338854,7/16/2014 17:02:03,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,SKIN causes PETECHIAE,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 18:36:07,,1324405125,7/16/2014 18:35:59,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 19:27:03,,1324433000,7/16/2014 19:26:25,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,337,372,,340,381,causes,0.447213595499958,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469052,7/16/2014 16:19:23,,1324321735,7/16/2014 16:19:03,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/16/2014 17:18:37,,1324343964,7/16/2014 17:18:17,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/16/2014 17:44:50,,1324361818,7/16/2014 17:44:36,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/16/2014 18:16:50,,1324395466,7/16/2014 18:16:08,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/16/2014 19:26:17,,1324432623,7/16/2014 19:25:42,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/16/2014 20:41:57,,1324467073,7/16/2014 20:41:16,prodege,0.6448,26325260,GBR,"","",79.64.25.64,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469052,7/17/2014 00:59:59,,1324594143,7/17/2014 00:59:29,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.993883734673619,907025-FS1-2,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
503469053,7/16/2014 15:53:43,,1324307808,7/16/2014 15:53:18,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 16:03:57,,1324312925,7/16/2014 16:03:18,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 16:19:00,,1324321633,7/16/2014 16:18:38,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,PARKINSON'S DISEASE treats L DOPA,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 16:49:23,,1324334476,7/16/2014 16:48:36,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 17:08:55,,1324341015,7/16/2014 17:08:30,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 17:18:16,,1324343906,7/16/2014 17:18:02,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469053,7/16/2014 20:40:21,,1324466364,7/16/2014 20:40:06,prodege,0.6448,26325260,GBR,"","",79.64.25.64,L DOPA treats PARKINSON'S DISEASE,44,158,,62,164,treats,0.991836598134176,908159-FS1-2,"The drug L Dopa is used in the treatment of PARKINSON'S DISEASE (PD), and patients often experience fluctuations in performance after a period of time taking L DOPA.",PARKINSON'S DISEASE,L DOPA,RO-may_treat
503469054,7/16/2014 15:28:16,,1324297708,7/16/2014 15:27:36,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 15:33:52,,1324299587,7/16/2014 15:33:37,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,PRO (B29) HUMAN INSULIN causes IDDM,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 15:37:23,,1324300866,7/16/2014 15:37:00,instagc,0.9028,13763729,USA,"","",75.182.89.225,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 16:24:42,,1324323818,7/16/2014 16:24:15,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,PRO (B29) HUMAN INSULIN causes IDDM,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 20:34:56,,1324464172,7/16/2014 20:34:13,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,IDDM causes PRO (B29) HUMAN INSULIN,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 22:52:20,,1324522209,7/16/2014 22:51:36,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 22:54:37,,1324523251,7/16/2014 22:54:07,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469055,7/16/2014 15:38:48,,1324301471,7/16/2014 15:38:24,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 15:53:26,,1324307658,7/16/2014 15:52:59,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 16:36:51,,1324328604,7/16/2014 16:36:28,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 17:23:24,,1324345477,7/16/2014 17:22:39,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 20:44:30,,1324467953,7/16/2014 20:44:25,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 21:38:12,,1324493259,7/16/2014 21:37:47,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469055,7/16/2014 22:19:41,,1324508952,7/16/2014 22:19:17,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,GRAM NEGATIVE SEPSIS causes SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,122,7,,160,27,causes,0.99654575824488,900353-FS1-4,"During GRAM NEGATIVE SEPSIS endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult respiratory distress syndrome.",SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GRAM NEGATIVE SEPSIS,RO-cause_of
503469056,7/16/2014 15:38:34,,1324301351,7/16/2014 15:38:14,instagc,0.9028,13763729,USA,"","",75.182.89.225,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 15:59:36,,1324310534,7/16/2014 15:59:21,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 16:40:00,,1324330645,7/16/2014 16:39:41,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,REFRACTORY STATUS EPILEPTICUS treats PROPOFOL,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 17:41:45,,1324358806,7/16/2014 17:41:07,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 17:45:05,,1324362065,7/16/2014 17:44:50,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 23:10:14,,1324528776,7/16/2014 23:09:31,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469056,7/16/2014 23:34:40,,1324539586,7/16/2014 23:34:25,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.995893206467704,907626-FS1-2,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
503469057,7/16/2014 15:49:44,,1324306076,7/16/2014 15:49:34,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,DRUG SIDE EFFECTS causes IMMUNOSUPPRESSIVE MEDICATIONS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 16:19:48,,1324321906,7/16/2014 16:18:47,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,IMMUNOSUPPRESSIVE MEDICATIONS causes DRUG SIDE EFFECTS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 17:07:02,,1324340354,7/16/2014 17:06:05,clixsense,0.5597,19638651,USA,"","",173.23.121.63,IMMUNOSUPPRESSIVE MEDICATIONS causes DRUG SIDE EFFECTS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 17:08:16,,1324340756,7/16/2014 17:07:45,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,IMMUNOSUPPRESSIVE MEDICATIONS causes DRUG SIDE EFFECTS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 19:45:20,,1324441935,7/16/2014 19:44:36,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 20:10:11,,1324452807,7/16/2014 20:10:05,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,DRUG SIDE EFFECTS causes IMMUNOSUPPRESSIVE MEDICATIONS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469057,7/16/2014 20:43:57,,1324467734,7/16/2014 20:43:46,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,IMMUNOSUPPRESSIVE MEDICATIONS causes DRUG SIDE EFFECTS,147,240,,175,257,causes,0.903696114115064,903594-FS1-4,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or IMMUNOSUPPRESSIVE MEDICATIONS ? An ophthalmologist for ocular involvement and to monitor for DRUG SIDE EFFECTS such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",IMMUNOSUPPRESSIVE MEDICATIONS,DRUG SIDE EFFECTS,RO-has_causative_agent
503469058,7/16/2014 15:30:01,,1324298297,7/16/2014 15:29:54,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,no_relation,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 15:30:41,,1324298573,7/16/2014 15:30:25,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 15:34:11,,1324299708,7/16/2014 15:33:53,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,AGGRESSIVE CLINICAL COURSE diagnosed by PLASMA CELL LEUKAEMIA,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 15:48:45,,1324305710,7/16/2014 15:48:22,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 16:41:11,,1324331362,7/16/2014 16:40:32,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,PLASMA CELL LEUKAEMIA diagnosed by AGGRESSIVE CLINICAL COURSE,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 17:02:30,,1324338939,7/16/2014 17:02:25,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,AGGRESSIVE CLINICAL COURSE diagnosed by PLASMA CELL LEUKAEMIA,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469058,7/16/2014 17:41:06,,1324358132,7/16/2014 17:40:27,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,PLASMA CELL LEUKAEMIA diagnosed by AGGRESSIVE CLINICAL COURSE,63,17,,88,38,diagnosed by,0.304997140665209,902607-FS1-13,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469059,7/16/2014 15:29:46,,1324298240,7/16/2014 15:29:38,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,HEADACHE causes CHRONIC MIGRAINE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:31:07,,1324298740,7/16/2014 15:30:42,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:33:37,,1324299495,7/16/2014 15:33:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,HEADACHE causes CHRONIC MIGRAINE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:49:16,,1324305878,7/16/2014 15:49:05,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 16:22:50,,1324323061,7/16/2014 16:22:23,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 17:07:35,,1324340573,7/16/2014 17:07:16,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 19:25:41,,1324432375,7/16/2014 19:24:49,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469060,7/16/2014 15:31:36,,1324298899,7/16/2014 15:31:08,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 15:32:19,,1324299132,7/16/2014 15:31:50,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 16:08:55,,1324316857,7/16/2014 16:08:30,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 16:23:08,,1324323177,7/16/2014 16:22:51,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 16:24:14,,1324323649,7/16/2014 16:23:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 16:47:01,,1324333563,7/16/2014 16:46:46,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469060,7/16/2014 17:45:05,,1324362066,7/16/2014 17:44:50,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.353553390593274,907942-FS1-2,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
503469061,7/16/2014 15:36:59,,1324300740,7/16/2014 15:36:41,instagc,0.9028,13763729,USA,"","",75.182.89.225,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:22:10,,1324322830,7/16/2014 16:21:53,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:24:42,,1324323821,7/16/2014 16:24:15,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,SEIZURES causes RIGHT PARIETAL PARASAGITTAL MENINGIOMA,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:50:04,,1324334674,7/16/2014 16:49:15,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:04:00,,1324339422,7/16/2014 17:03:42,clixsense,0.5597,19638651,USA,"","",173.23.121.63,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:22:38,,1324345158,7/16/2014 17:22:08,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:42:10,,1324359200,7/16/2014 17:41:47,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,SEIZURES causes RIGHT PARIETAL PARASAGITTAL MENINGIOMA,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469062,7/16/2014 17:43:17,,1324360279,7/16/2014 17:42:43,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,PROGERIA SYNDROME (HGPS) causes PREMATURE AGING,77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 19:10:39,,1324424829,7/16/2014 19:10:01,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,PREMATURE AGING causes PROGERIA SYNDROME (HGPS),77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 19:46:09,,1324442288,7/16/2014 19:45:43,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 22:56:58,,1324524240,7/16/2014 22:56:28,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 23:50:16,,1324545717,7/16/2014 23:50:04,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,PROGERIA SYNDROME (HGPS) causes PREMATURE AGING,77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/17/2014 00:28:11,,1324564393,7/17/2014 00:27:47,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/17/2014 02:19:04,,1324671181,7/17/2014 02:18:49,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PREMATURE AGING causes PROGERIA SYNDROME (HGPS),77,122,,91,146,causes,0.539359889970594,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469063,7/16/2014 15:30:01,,1324298306,7/16/2014 15:29:54,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 15:43:20,,1324303327,7/16/2014 15:43:11,instagc,0.8194,18960682,GBR,"","",86.29.147.112,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 15:59:59,,1324310687,7/16/2014 15:59:37,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:08:16,,1324340758,7/16/2014 17:07:45,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:19:16,,1324344187,7/16/2014 17:18:53,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:23:24,,1324345472,7/16/2014 17:22:39,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 18:18:17,,1324397079,7/16/2014 18:17:33,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469064,7/16/2014 15:28:39,,1324297851,7/16/2014 15:28:17,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,DCIS causes BRANCHING (CASTING TYPE CALCIFICATIONS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 15:55:04,,1324308364,7/16/2014 15:54:30,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,BRANCHING (CASTING TYPE CALCIFICATIONS causes DCIS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 16:24:07,,1324323583,7/16/2014 16:23:41,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 16:39:30,,1324330405,7/16/2014 16:39:19,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,BRANCHING (CASTING TYPE CALCIFICATIONS causes DCIS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 17:02:02,,1324338837,7/16/2014 17:01:51,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,BRANCHING (CASTING TYPE CALCIFICATIONS causes DCIS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 20:02:10,,1324449358,7/16/2014 20:01:42,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,DCIS causes BRANCHING (CASTING TYPE CALCIFICATIONS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469064,7/16/2014 20:09:45,,1324452620,7/16/2014 20:09:38,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,BRANCHING (CASTING TYPE CALCIFICATIONS causes DCIS,101,72,,138,76,causes,0.956182887467515,902562-FS1-4,Multiple calcifications occurred in the necrotic core of the continuous DCIS resulting in linear and BRANCHING (CASTING TYPE CALCIFICATIONS a hallmark of high grade DCIS on mammograms.,BRANCHING (CASTING TYPE CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469065,7/16/2014 17:42:42,,1324359693,7/16/2014 17:42:11,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 20:35:43,,1324464490,7/16/2014 20:34:57,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 23:09:32,,1324528528,7/16/2014 23:08:48,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 23:31:08,,1324538075,7/16/2014 23:30:31,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 00:28:58,,1324565142,7/17/2014 00:28:35,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 02:19:22,,1324671423,7/17/2014 02:19:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 02:32:39,,1324684655,7/17/2014 02:31:56,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.433012701892219,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469066,7/16/2014 15:26:54,,1324297323,7/16/2014 15:26:35,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,AGGRESSIVE CLINICAL COURSE causes PLASMA CELL LEUKAEMIA,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 16:37:20,,1324328883,7/16/2014 16:37:07,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 16:52:23,,1324335433,7/16/2014 16:51:56,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,AGGRESSIVE CLINICAL COURSE causes PLASMA CELL LEUKAEMIA,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 23:48:32,,1324545086,7/16/2014 23:47:49,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 00:59:11,,1324593236,7/17/2014 00:58:38,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 02:20:23,,1324672426,7/17/2014 02:20:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 02:23:09,,1324675133,7/17/2014 02:22:14,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,no_relation,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469067,7/16/2014 15:23:33,,1324296344,7/16/2014 15:23:15,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 15:27:10,,1324297380,7/16/2014 15:26:35,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 15:48:55,,1324305763,7/16/2014 15:48:37,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 16:08:55,,1324316860,7/16/2014 16:08:30,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 17:08:55,,1324341016,7/16/2014 17:08:30,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,no_relation,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 18:04:10,,1324382130,7/16/2014 18:03:59,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469067,7/16/2014 19:10:00,,1324424490,7/16/2014 19:09:26,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,no_relation,66,54,,84,62,treats,0.696310623822791,907899-FS1-2,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503469068,7/16/2014 16:19:48,,1324321910,7/16/2014 16:18:47,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 18:03:10,,1324381091,7/16/2014 18:02:21,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 19:54:28,,1324446339,7/16/2014 19:54:08,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 20:35:43,,1324464491,7/16/2014 20:34:57,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 21:37:45,,1324493112,7/16/2014 21:37:15,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 23:11:30,,1324529241,7/16/2014 23:10:51,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469068,7/16/2014 23:29:58,,1324537563,7/16/2014 23:29:29,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,150,97,,176,112,diagnosed by,0.387298334620742,908304-FS1-13,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469069,7/16/2014 15:31:50,,1324298978,7/16/2014 15:31:21,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,LAMELAR BONE is location of BONE PAIN,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 16:15:27,,1324320181,7/16/2014 16:14:40,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,BONE PAIN is location of LAMELAR BONE,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 16:21:07,,1324322422,7/16/2014 16:20:27,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,no_relation,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 16:47:33,,1324333770,7/16/2014 16:47:26,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,LAMELAR BONE is location of BONE PAIN,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 17:41:45,,1324358807,7/16/2014 17:41:07,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 23:29:06,,1324537244,7/16/2014 23:28:41,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469069,7/16/2014 23:50:16,,1324545714,7/16/2014 23:50:04,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,LAMELAR BONE is location of BONE PAIN,113,91,,124,100,is location of,0.589767824619588,905427-FS1-9,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469070,7/16/2014 15:34:18,,1324299736,7/16/2014 15:34:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,METASTATIC MULTIPLE MYELOMA treats ZOLEDRONIC ACID,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 16:18:33,,1324321493,7/16/2014 16:18:08,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 16:21:37,,1324322631,7/16/2014 16:21:08,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 17:08:28,,1324340849,7/16/2014 17:08:08,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 17:44:11,,1324361140,7/16/2014 17:44:02,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 18:04:33,,1324382538,7/16/2014 18:04:11,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 22:55:47,,1324523741,7/16/2014 22:54:54,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.903696114115064,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469071,7/16/2014 15:49:03,,1324305805,7/16/2014 15:48:47,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 15:49:19,,1324305898,7/16/2014 15:49:10,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,CATARACT FORMATION causes LENS,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 16:18:33,,1324321474,7/16/2014 16:18:08,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,LENS causes CATARACT FORMATION,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 16:22:22,,1324322886,7/16/2014 16:21:45,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 16:51:44,,1324335219,7/16/2014 16:50:57,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 17:07:43,,1324340611,7/16/2014 17:07:23,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,CATARACT FORMATION causes LENS,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469071,7/16/2014 17:18:37,,1324343967,7/16/2014 17:18:17,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,177,198,,180,216,causes,0.560112033611204,905038-FS1-4,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469072,7/16/2014 15:31:07,,1324298739,7/16/2014 15:30:42,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 15:53:13,,1324307570,7/16/2014 15:52:18,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,PLASMA GLUCOSE causes HYPOGLYCEMIA,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 16:19:00,,1324321632,7/16/2014 16:18:38,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,PLASMA GLUCOSE causes HYPOGLYCEMIA,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 18:25:41,,1324400256,7/16/2014 18:25:10,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 19:12:02,,1324425477,7/16/2014 19:11:21,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,no_relation,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 20:10:04,,1324452755,7/16/2014 20:09:55,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,PLASMA GLUCOSE causes HYPOGLYCEMIA,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469072,7/16/2014 20:44:05,,1324467781,7/16/2014 20:43:58,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,PLASMA GLUCOSE causes HYPOGLYCEMIA,173,109,,184,123,causes,0.640512615220348,908276-FS1-4,The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring PLASMA GLUCOSE but little is known about molecular responses to HYPOGLYCEMIA that may also be neuroprotective.,HYPOGLYCEMIA,PLASMA GLUCOSE,RO-may_treat
503469073,7/16/2014 15:26:54,,1324297313,7/16/2014 15:26:35,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/16/2014 23:34:40,,1324539587,7/16/2014 23:34:25,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/16/2014 23:50:04,,1324545629,7/16/2014 23:49:35,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,TUBERCULOSIS causes TUBERCULIN NEGATIVE,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 02:23:52,,1324675783,7/17/2014 02:23:32,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 02:31:55,,1324683929,7/17/2014 02:31:12,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 03:07:59,,1324720684,7/17/2014 03:07:39,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 03:39:44,,1324751265,7/17/2014 03:38:57,instagc,0.5238,20183814,USA,"","",166.182.81.199,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469074,7/16/2014 15:55:04,,1324308363,7/16/2014 15:54:30,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,IRON causes IRON DEFICIENCY ANEMIA,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 18:35:38,,1324404896,7/16/2014 18:35:29,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 21:39:42,,1324493889,7/16/2014 21:39:20,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 23:35:05,,1324539740,7/16/2014 23:34:42,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 00:50:28,,1324584522,7/17/2014 00:49:28,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 02:22:13,,1324674191,7/17/2014 02:21:33,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,no_relation,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 03:07:37,,1324720207,7/17/2014 03:06:58,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,IRON causes IRON DEFICIENCY ANEMIA,96,96,,117,100,causes,0.485071250072666,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469075,7/16/2014 15:30:45,,1324298607,7/16/2014 15:30:19,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 17:18:52,,1324344045,7/16/2014 17:18:38,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 18:03:58,,1324381892,7/16/2014 18:03:28,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 18:26:24,,1324400587,7/16/2014 18:25:42,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 20:09:54,,1324452655,7/16/2014 20:09:47,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,PAPULES causes LYMPHOMATOID PAPULOSIS,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/17/2014 00:28:35,,1324564769,7/17/2014 00:28:12,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/17/2014 02:33:15,,1324685408,7/17/2014 02:32:40,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469076,7/16/2014 15:29:37,,1324298205,7/16/2014 15:29:30,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,MALT LYMPHOMAS causes LYMPHOEPITHELIAL LESIONS,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 15:43:35,,1324303474,7/16/2014 15:43:22,instagc,0.8194,18960682,GBR,"","",86.29.147.112,no_relation,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 16:47:09,,1324333641,7/16/2014 16:47:02,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,MALT LYMPHOMAS causes LYMPHOEPITHELIAL LESIONS,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 16:52:59,,1324335681,7/16/2014 16:52:28,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,LYMPHOEPITHELIAL LESIONS causes MALT LYMPHOMAS,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 17:08:06,,1324340721,7/16/2014 17:07:36,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,MALT LYMPHOMAS causes LYMPHOEPITHELIAL LESIONS,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 17:29:44,,1324349126,7/16/2014 17:29:09,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,LYMPHOEPITHELIAL LESIONS causes MALT LYMPHOMAS,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469076,7/16/2014 20:02:10,,1324449361,7/16/2014 20:01:42,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,115,200,,138,214,causes,0.629940788348712,902863-FS1-4,High grade lymphomas were classified in three groups based on the presence or absence of a low grade component and LYMPHOEPITHELIAL LESIONS (LELs): 1) high grade MALT lymphomas appearing in low grade MALT LYMPHOMAS (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high grade LELs) but without a low grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low grade MALT lymphoma component or LELs (DLCL.,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,RO-disease_may_have_finding
503469077,7/16/2014 15:40:25,,1324302139,7/16/2014 15:39:47,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 16:39:39,,1324330473,7/16/2014 16:39:31,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERTENSION causes ELEVATED BP,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:03:40,,1324339267,7/16/2014 17:03:21,neodev,0.375,12218487,CAN,ON,Oshawa,174.117.79.122,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:05:24,,1324339812,7/16/2014 17:04:35,clixsense,0.5597,19638651,USA,"","",173.23.121.63,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:45:22,,1324362347,7/16/2014 17:45:06,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,ELEVATED BP causes HYPERTENSION,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 18:15:34,,1324393878,7/16/2014 18:14:41,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,ELEVATED BP causes HYPERTENSION,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 19:26:17,,1324432622,7/16/2014 19:25:42,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469078,7/16/2014 16:52:20,,1324335404,7/16/2014 16:51:47,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/16/2014 17:30:21,,1324349588,7/16/2014 17:29:59,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/16/2014 20:42:17,,1324467162,7/16/2014 20:41:59,prodege,0.6448,26325260,GBR,"","",79.64.25.64,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/17/2014 02:19:22,,1324671422,7/17/2014 02:19:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/17/2014 02:23:32,,1324675475,7/17/2014 02:23:10,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/17/2014 02:29:23,,1324681458,7/17/2014 02:28:43,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469078,7/17/2014 03:08:18,,1324720938,7/17/2014 03:08:00,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,PARACETAMOL treats PAIN,76,60,,79,71,treats,0.997054485501582,908195-FS1-2,Measles patients with an acute ear infection should receive PARACETAMOL for PAIN and fever and an antibiotic for the infection.,PAIN,PARACETAMOL,RO-may_treat
503469079,7/16/2014 16:17:59,,1324321257,7/16/2014 16:16:58,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,COMPLEX FEBRILE SEIZURES causes EPILEPSY,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/16/2014 17:05:24,,1324339816,7/16/2014 17:04:35,clixsense,0.5597,19638651,USA,"","",173.23.121.63,COMPLEX FEBRILE SEIZURES causes EPILEPSY,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/16/2014 22:03:06,,1324502959,7/16/2014 22:02:35,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,COMPLEX FEBRILE SEIZURES causes EPILEPSY,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/16/2014 22:20:32,,1324509430,7/16/2014 22:20:14,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,EPILEPSY causes COMPLEX FEBRILE SEIZURES,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/17/2014 00:27:47,,1324564050,7/17/2014 00:27:16,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/17/2014 02:20:32,,1324672627,7/17/2014 02:20:24,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,EPILEPSY causes COMPLEX FEBRILE SEIZURES,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469079,7/17/2014 02:32:39,,1324684672,7/17/2014 02:31:56,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,COMPLEX FEBRILE SEIZURES causes EPILEPSY,337,449,,360,457,causes,0.943879807448539,904843-FS1-4,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? COMPLEX FEBRILE SEIZURES ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of EPILEPSY is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",COMPLEX FEBRILE SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503469080,7/16/2014 16:04:38,,1324313403,7/16/2014 16:04:03,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 16:23:08,,1324323178,7/16/2014 16:22:51,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 16:25:08,,1324323956,7/16/2014 16:24:43,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 17:03:40,,1324339266,7/16/2014 17:03:21,neodev,0.375,12218487,CAN,ON,Oshawa,174.117.79.122,VENTRICULAR TACHYCARDIA (VT) treats QUINIDINE,86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 17:07:28,,1324340517,7/16/2014 17:07:02,clixsense,0.5597,19638651,USA,"","",173.23.121.63,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 18:03:27,,1324381351,7/16/2014 18:03:12,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469080,7/16/2014 19:10:00,,1324424492,7/16/2014 19:09:26,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,QUINIDINE treats VENTRICULAR TACHYCARDIA (VT),86,31,,113,40,treats,0.983869910099907,907007-FS1-2,The efficacy of mexiletine and QUINIDINE in controlling ventricular couplets (VC) and VENTRICULAR TACHYCARDIA (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,VENTRICULAR TACHYCARDIA (VT),QUINIDINE,RO-may_prevent
503469081,7/16/2014 15:25:53,,1324297059,7/16/2014 15:25:40,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,BLEPHAROSPASM treats TYPE A BOTULINUM TOXIN,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 15:39:43,,1324301894,7/16/2014 15:39:12,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 15:52:33,,1324307340,7/16/2014 15:52:04,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 15:53:13,,1324307571,7/16/2014 15:52:18,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,BLEPHAROSPASM treats TYPE A BOTULINUM TOXIN,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 20:03:44,,1324449947,7/16/2014 20:03:29,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 20:10:11,,1324452832,7/16/2014 20:10:05,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469081,7/16/2014 22:03:06,,1324502966,7/16/2014 22:02:35,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.995037190209989,908035-FS1-2,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
503469082,7/16/2014 15:34:24,,1324299765,7/16/2014 15:34:19,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,GENERALIZED HIVES is location of SKIN,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 15:40:57,,1324302404,7/16/2014 15:40:27,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,SKIN is location of GENERALIZED HIVES,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 16:47:25,,1324333727,7/16/2014 16:47:18,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,GENERALIZED HIVES is location of SKIN,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 16:50:20,,1324334760,7/16/2014 16:49:25,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,SKIN is location of GENERALIZED HIVES,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 18:03:27,,1324381353,7/16/2014 18:03:12,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,SKIN is location of GENERALIZED HIVES,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 20:36:15,,1324464712,7/16/2014 20:35:40,bitcoinget,0.8333,27766138,USA,AL,Birmingham,12.208.238.130,SKIN is location of GENERALIZED HIVES,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469082,7/16/2014 20:41:15,,1324466775,7/16/2014 20:40:22,prodege,0.6448,26325260,GBR,"","",79.64.25.64,SKIN is location of GENERALIZED HIVES,72,108,,75,125,is location of,0.983078304622849,902176-FS1-9,"Acute onset of an illness (over minutes to several hours) involving the SKIN mucosal tissue, or both (e.g., GENERALIZED HIVES; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",SKIN,GENERALIZED HIVES,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 15:30:24,,1324298467,7/16/2014 15:29:45,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 16:50:04,,1324334677,7/16/2014 16:49:15,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,CENTRAL NERVOUS SYSTEM causes MEDULLOBLASTOMAS,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 20:03:44,,1324449946,7/16/2014 20:03:29,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 21:39:18,,1324493665,7/16/2014 21:39:01,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 22:19:17,,1324508720,7/16/2014 22:18:46,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/16/2014 23:35:05,,1324539741,7/16/2014 23:34:42,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469083,7/17/2014 02:18:49,,1324670850,7/17/2014 02:18:34,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,no_relation,0,97,,21,113,causes,0.686802819743445,902273-FS1-4,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469084,7/16/2014 15:26:33,,1324297238,7/16/2014 15:26:12,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,CEREBELLUM is location of CEREBELLAR ATAXIA,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/16/2014 17:44:35,,1324361534,7/16/2014 17:44:11,gifthulk,0.7524,21916793,GBR,"","",87.113.87.199,CEREBELLUM is location of CEREBELLAR ATAXIA,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/16/2014 19:08:44,,1324423793,7/16/2014 19:07:49,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,CEREBELLUM is location of CEREBELLAR ATAXIA,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/16/2014 19:25:41,,1324432376,7/16/2014 19:24:49,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,CEREBELLAR ATAXIA is location of CEREBELLUM,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/16/2014 22:53:14,,1324522597,7/16/2014 22:52:21,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/16/2014 23:48:32,,1324545082,7/16/2014 23:47:49,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,CEREBELLUM is location of CEREBELLAR ATAXIA,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469084,7/17/2014 00:28:58,,1324565143,7/17/2014 00:28:35,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,80,18,,89,35,is location of,0.855186110494136,905449-FS1-9,The laterality of CEREBELLAR ATAXIA was significantly correlated with AI in the CEREBELLUM in patients with sOPCA.,CEREBELLUM,CEREBELLAR ATAXIA,RO-has_finding_site
503469085,7/16/2014 15:59:59,,1324310688,7/16/2014 15:59:37,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 16:37:05,,1324328775,7/16/2014 16:36:52,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 16:50:48,,1324334903,7/16/2014 16:50:08,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 17:22:38,,1324345166,7/16/2014 17:22:08,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 18:04:51,,1324382838,7/16/2014 18:04:34,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 18:35:38,,1324404894,7/16/2014 18:35:29,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469085,7/16/2014 19:10:39,,1324424828,7/16/2014 19:10:01,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,FLUORIDE treats DENTAL CARIES,45,75,,57,83,treats,0.994134846772434,907223-FS1-2,This paper reviews the probable mechanism of DENTAL CARIES and the role of FLUORIDE in the inhibition or reversal of that process.,DENTAL CARIES,FLUORIDE,RO-may_prevent
503469086,7/16/2014 15:31:20,,1324298774,7/16/2014 15:30:46,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 15:43:10,,1324303266,7/16/2014 15:42:56,instagc,0.8194,18960682,GBR,"","",86.29.147.112,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 17:07:22,,1324340501,7/16/2014 17:06:11,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,IDDM treats PRO (B29) HUMAN INSULIN,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 19:12:02,,1324425475,7/16/2014 19:11:21,vivatic,0.6952,25451531,GBR,"","",83.67.28.193,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 20:00:52,,1324448870,7/16/2014 19:59:55,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,no_relation,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 22:20:32,,1324509429,7/16/2014 22:20:14,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 22:51:34,,1324521891,7/16/2014 22:50:42,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469087,7/16/2014 15:26:15,,1324297152,7/16/2014 15:25:57,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,MEDULLOBLASTOMAS is location of CENTRAL NERVOUS SYSTEM,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 15:29:08,,1324297985,7/16/2014 15:28:08,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,CENTRAL NERVOUS SYSTEM is location of MEDULLOBLASTOMAS,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 15:29:54,,1324298284,7/16/2014 15:29:47,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,CENTRAL NERVOUS SYSTEM is location of MEDULLOBLASTOMAS,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 16:39:30,,1324330399,7/16/2014 16:39:19,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,MEDULLOBLASTOMAS is location of CENTRAL NERVOUS SYSTEM,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 16:47:17,,1324333701,7/16/2014 16:47:11,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,MEDULLOBLASTOMAS is location of CENTRAL NERVOUS SYSTEM,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 19:46:09,,1324442296,7/16/2014 19:45:43,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
503469087,7/16/2014 20:44:24,,1324467927,7/16/2014 20:44:18,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,MEDULLOBLASTOMAS is location of CENTRAL NERVOUS SYSTEM,0,97,,21,113,is location of,0.686802819743445,902273-FS1-9,"CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors are devastating cancers in children, consisting of MEDULLOBLASTOMAS CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,RO-disease_has_primary_anatomic_site
